홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
CLDX
#3995
Celldex Therapeutics, Inc
30.090
0
+0.40%
부문:
베이스:
수익 통화:
일일 변동 비율
년간 변동
일일 변동
+0.40%
월간 변동
+14.80%
6달 변화
+10.46%
년간 변동율
+10.46%
이전 종가
29.970
0
Open
30.000
0
Bid
Ask
Low
30.000
0
High
30.090
0
양
102
마켓
주식
헬스케어
CLDX
Open full chart
Financials
Overview
성명
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
66.34 M
66.38 M
66.39 M
66.41 M
66.45 M
66.57 M
—
Valuation ratios
Enterprise value
2.22 B
1.65 B
1.19 B
1.33 B
1.68 B
1.78 B
5.98 B
Price to earnings ratio
-13.17
-10.31
-6.72
-6.76
-7.65
-6.96
-28.1
Price to sales ratio
0.2
0.23
0.16
0.23
0.65
1.17
2.21
Price to cash flow ratio
0.01
0.01
0.01
0.01
0.01
0.01
0.03
Price to book ratio
0
0
0
0
0
0
0
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.06
-0.02
0.08
0.08
0.1
0.14
0.41
Return on equity %
0.07
-0.02
0.09
0.09
0.11
0.15
0.44
Return on invested capital %
—
-113.71
—
—
—
-176.27
—
Gross margin %
100
100
100
100
100
100
400
Operating margin %
1 633.53
4 768.26
9 027.19
8 747.53
-7.36 M
72.03 K
-7.27 M
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
1 633.53
-1 145.36
9 027.19
7 753.97
-6.7 M
67.24 K
-6.62 M
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
24.27
18.91
21.67
19.67
13.01
10.49
64.83
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0
0
0
0
-0
0
0
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
834.69
504.67
819.49
662.73
731.71
962.71
3 176.63
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
11.4 K
11.26 K
10.14 K
9 494.17
8 780.83
7 807.25
36.22 K
Net current asset value per share
11.75 K
11.6 K
10.45 K
9 766.3
9 098.75
8 049.5
37.37 K
Tangible book value per share
11.44 K
11.18 K
10.18 K
9 462.22
8 599.41
7 527.25
35.77 K
Working capital per share
11.26 K
10.99 K
9 968.5
9 269.81
8 399.19
7 281.82
34.92 K
Book value per share
11.85 K
11.6 K
10.59 K
9 871.76
9 008.78
7 936.6
37.41 K
뉴스
셀덱스, 만성 두드러기 치료제 2상 데이터 발표
Celldex presents phase 2 data for chronic urticaria treatment
Celldex Therapeutics Stock Earns 88 RS Rating
Celldex Therapeutics Q4 실적, 수익 에상치보다 저조
Celldex Therapeutics earnings missed by $0.21, revenue fell short of estimates
셀덱스 테라퓨틱스, 52주 최고가 30.66달러 기록
Celldex Therapeutics stock hits 52-week high at 30.66 USD
Stifel, 셀덱스 테라퓨틱스에 ’매수’ 등급 유지
Stifel reiterates Celldex Therapeutics stock rating on trial progress
Celldex, CSU 치료제 3상 등록 완료, 예상보다 빨라
Celldex completes Phase 3 enrollment for CSU treatment ahead of schedule
셀덱스 테라퓨틱스, Cantor Fitzgerald ’비중확대’ 등급 유지